| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Curis Inc (CRIS) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. CRIS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 360.0K | $202.0K | - | |
| CFO | 135.0K | $75.7K | - | |
| Other | 135.0K | $75.7K | - | |
| Dir | 14.4K | $8.1K | - | |
| Dir | 14.4K | $8.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Dentzer James E | President &CEO | Sell | 5,500 | $3.12 | $17,149.66 | -4.0% | -68.9% | -77.0% | |
| Jan 26, 2021 | Dentzer James E | President &CEO | Sell | 5,377 | $10.75 | $57,779.71 | -3.8% | - | - | |
| Jan 24, 2020 | Dentzer James E | President &CEO | Sell | 6,752 | $1.67 | $11,257.98 | -7.2% | - | - | |
| Jan 24, 2019 | Dentzer James E | President &CEO | Sell | 5,491 | $1.13 | $6,189.70 | -6.0% | - | - | |
| Jan 23, 2019 | Kaitin Kenneth I | Director | Sell | 14,800 | $1.05 | $15,587.36 | -34.5% | - | - | |
| Jan 23, 2019 | Greenacre Martyn D | Director | Sell | 18,500 | $1.05 | $19,474.95 | -41.5% | - | - | |
| Jan 23, 2019 | Kunkel Lori Anne | Director | Sell | 14,800 | $1.05 | $15,581.44 | -40.0% | - | - | |
| Jan 23, 2019 | Martell Robert | Head Of Research &Development | Sell | 5,500 | $1.07 | $5,900.40 | -19.3% | - | - | |
| Jan 23, 2019 | Rubin Marc | Director | Sell | 18,500 | $1.05 | $19,476.80 | -39.1% | - | - | |
| Nov 16, 2017 | Rubin Marc | Director | Buy | 25,000 | $0.98 | $24,500.00 | +94.0% | - | - |